# Project Brief: MetaboWell

**Document Version:** 1.0  
**Date:** November 2, 2025  
**Prepared By:** Mary, Business Analyst  
**Status:** Draft for Review

---

## Executive Summary

**MetaboWell** is India's first doctor-led metabolic health ecosystem, combining in-person endocrinologist consultations (in Visakhapatnam) with digital follow-up care, GLP-1 therapy management, and holistic lifestyle support. The platform addresses the critical gap in Indian healthcare where patients receive prescriptions but lack ongoing support, coordination, and community‚Äîespecially critical for GLP-1 medications that require long-term management, side effect monitoring, and lifestyle integration.

**Primary Problem:** Obese and metabolically compromised Indians struggle with fragmented healthcare‚Äîscattered consultations, no continuity of care, lack of GLP-1 expertise, and absence of integrated support (nutrition, diagnostics, pharmacy, community). Existing solutions are either digital-only (lacking trust), transactional (no ongoing relationships), or hospital-based (expensive and inconvenient).

**Target Market:** Adults 30-55 in Tier-1 and Tier-2 India (starting with Visakhapatnam) with obesity (BMI 30+), Type-2 diabetes, PCOS, or metabolic disorders who have tried traditional weight loss methods unsuccessfully.

**Key Value Proposition:** "Your metabolic health partner for life‚Äînot just an app, not just a consultation, but a relationship with your endocrinologist, nutritionist, and community, all coordinated through one platform."

---

## Problem Statement

### Current State and Pain Points

**The Metabolic Health Crisis in India:**
- 135M+ Indians living with obesity and metabolic disorders
- $3.7B weight management market (2024), growing at 9.5% CAGR
- GLP-1 medications (Mounjaro, Ozempic, Wegovy) are revolutionary but require expertise and ongoing support

**Patient Journey Fragmentation:**
1. **Initial Consultation:** Patients visit doctors who may lack GLP-1 expertise or prescribe without comprehensive diagnostics
2. **No Ongoing Support:** Doctors follow "examine and prescribe" model‚Äîpatients abandoned after prescription
3. **Side Effect Management:** GLP-1 side effects (nausea, constipation, fatigue) emerge but no accessible support
4. **Plateau Frustration:** Weight loss plateaus common, but no timely medical guidance
5. **Lifestyle Integration:** Dietician support critical but fragmented‚Äîpatients must find separately
6. **Medication Access:** Pharmacy coordination and affordability challenges
7. **Long-term Maintenance:** Rebound after stopping medication‚Äîno structured off-ramp or maintenance protocols

### Impact of the Problem

**Quantified Impact:**
- **Yo-yo dieting costs:** Patients spend ‚Çπ50,000-‚Çπ1,00,000 on failed weight loss attempts over years
- **Diabetes complications:** Untreated metabolic disorders lead to ‚Çπ1L+ hospitalization costs
- **Lost productivity:** Obesity/metabolic disorders reduce work performance, increase sick days
- **Emotional toll:** Shame, frustration, isolation‚Äîpatients feel like failures

**Healthcare System Gaps:**
- Doctors see 25-30 patients/day‚Äîno time for ongoing support
- Telemedicine platforms (Practo, Apollo) offer transactions, not relationships
- GLP-1 programs (HealthifyRx) are digital-only, metro-centric, coach-led (not doctor-led)
- No integrated platforms combining endocrinology + nutrition + diagnostics + pharmacy + community

### Why Existing Solutions Fall Short

**HealthifyRx (Primary Competitor):**
- ‚ùå Digital-only‚Äîno physical consultations (trust barrier in Tier-2)
- ‚ùå Coach-led, not endocrinologist-led (medical complexity not addressed)
- ‚ùå Weight loss focus only (ignores PCOS, diabetes, hormonal health)
- ‚ùå Premium pricing (‚Çπ48K-‚Çπ80K) excludes Tier-2 market
- ‚ùå No regional language support

**General Telemedicine (Practo, Apollo, Tata 1mg):**
- ‚ùå Marketplace model‚Äîno continuity of care (different doctor each time)
- ‚ùå Transactional consultations‚Äîno structured programs
- ‚ùå No GLP-1 expertise or protocols
- ‚ùå No community or lifestyle support integration

**Hospital-Based Programs:**
- ‚ùå Expensive and inconvenient (travel time, wait times)
- ‚ùå Fragmented departments (endocrinology, nutrition, pharmacy separate)
- ‚ùå "Prescribe and abandon" model persists

**Regional Players:**
- ‚ùå Limited specialized metabolic health platforms in Tier-2 cities
- ‚ùå No technology integration or digital follow-up
- ‚ùå Fragmented individual practitioners

### Urgency and Importance

**Market Timing Factors:**
1. **GLP-1 Revolution:** Ozempic approved Oct 2024, Mounjaro launched in India (becoming 2nd highest selling branded drug Aug 2025)
2. **Generic Arrival:** Semaglutide patents expire 2026‚ÄîIndian pharma will flood market, 85-90% cost reduction (‚Çπ30K ‚Üí ‚Çπ3K/month)
3. **Tier-2 Telemedicine Boom:** 7x growth in online consultations in Tier-2 cities (Practo data)
4. **Eli Lilly Investment:** $1B plant in India signals long-term commitment to GLP-1 market
5. **Competitive Window:** 24-36 month window before well-funded players (Mosaic, Apollo) enter metabolic health vertically

**Why Solve This Now:**
- First-mover advantage in Tier-2 metabolic health category
- GLP-1 medications require specialized support‚Äîearly platform captures trust
- Capital-efficient regional dominance possible before national scale
- Founder's local credibility (Chamber of Commerce past president) creates defensible moat

---

## Proposed Solution

### Core Concept and Approach

**MetaboWell** is a hybrid metabolic health platform that combines:

1. **Physical Consultations in Visakhapatnam** ‚Üí Builds trust (critical in Tier-2)
2. **Digital Follow-up India-Wide** ‚Üí Convenience and scalability
3. **Endocrinologist-Led Care** ‚Üí Medical rigor for complex metabolic disorders
4. **Integrated Ecosystem** ‚Üí Doctors + Labs + Pharmacy + Dieticians + Community in ONE platform
5. **Longitudinal Programs** ‚Üí 6-12 month relationships, not one-off consultations
6. **Transparent Pricing** ‚Üí ‚Çπ3,500/month standard, ‚Çπ6,000/month with GLP-1 (plus medication)

### Key Differentiators from Existing Solutions

| Differentiator | MetaboWell | Competitors |
|----------------|------------|-------------|
| **Service Model** | Hybrid (physical + digital) | Digital-only or hospital-only |
| **Medical Leadership** | Endocrinologist-led | Coach-led or marketplace |
| **Care Continuity** | Assigned doctor (same throughout journey) | Random doctors (marketplace) |
| **Integration** | All services coordinated (one platform) | Fragmented (separate providers) |
| **Geographic Focus** | Tier-2 first (Vizag ‚Üí expansion) | Metro-centric |
| **Pricing Transparency** | Upfront, no hidden costs | Opaque or premium-only |
| **Community Support** | Peer groups, WhatsApp communities | Isolated coaching |
| **Scope** | Metabolic health (diabetes, PCOS, obesity, hormones) | Weight loss only or general wellness |

### Why This Solution Will Succeed

**1. Trust Through Hybrid Model:**
- Physical consultations in Vizag build credibility (Tier-2 patients skeptical of pure telemedicine)
- Digital follow-up provides convenience after trust established
- HealthifyRx can't replicate without changing entire digital-only model

**2. Medical Rigor Creates Switching Costs:**
- Endocrinologist relationships are sticky (6-12 month programs)
- Medical history, progress tracking, personalized protocols create lock-in
- Competitors (coach-led) can't handle complex cases requiring medical expertise

**3. Regional Dominance Before National Scale:**
- First-mover in Vizag (2M+ population, 100K+ with metabolic disorders)
- Founder's local credibility accelerates adoption
- By the time national players notice, MetaboWell owns regional market

**4. Integrated Care Reduces Friction:**
- Patients don't have to coordinate doctors, labs, pharmacies, dieticians separately
- "One platform, one team, one journey" eliminates fragmentation
- Creates value proposition competitors can't match without massive integration

**5. Community and Belonging Drive Retention:**
- Peer support groups reduce isolation
- Sense of belonging transforms from service to lifestyle
- Big platforms optimize for scale‚ÄîMetaboWell optimizes for relationships

### High-Level Vision for the Product

**Phase 1 (Months 1-6): MVP in Visakhapatnam**
- Physical clinic + video consultations
- 5 endocrinologists, 3 dieticians
- Basic EHR, patient tracking, WhatsApp support
- 200 users target

**Phase 2 (Months 7-18): Digital Scale + Expansion**
- Mobile app launch
- Expand to Vijayawada, Hyderabad (partner clinics)
- Advanced tracking, community features, regional language support
- 1,000 users target

**Phase 3 (Months 19-36): GLP-1 + Nationwide + Corporate**
- Full GLP-1 therapy program
- Corporate wellness (B2B)
- Insurance partnerships
- 10+ Tier-2 cities
- 5,000+ users target

**Long-term Vision (3-5 years):**
- India's leading metabolic health platform
- 50,000+ patients creating network effects
- Category-defining brand ("MetaboWell = metabolic health")
- International expansion (adapt model for other emerging markets)

---

## Target Users

### Primary User Segment: Obese/Overweight Adults Seeking Metabolic Health

**Demographic Profile:**
- **Age:** 30-55 years
- **Location:** Tier-1 cities (Mumbai, Delhi, Bangalore) and Tier-2 cities (Vizag, Vijayawada, Hyderabad)
- **Income:** ‚Çπ10-20L+ annually (can afford ‚Çπ3,500-‚Çπ6,000/month)
- **BMI:** 30+ (obese) or 27+ with comorbidities (diabetes, PCOS, hypertension)
- **Gender:** 60% women (PCOS, hormonal issues), 40% men

**Current Behaviors and Workflows:**
- **Past Weight Loss Attempts:** Tried 5-10 diets, gym memberships, fasting‚Äîalways rebounds
- **Healthcare Seeking:** Visit general practitioners or endocrinologists sporadically (no continuity)
- **Information Sources:** Google searches, YouTube videos, WhatsApp forwards (often inaccurate)
- **Medication Experience:** Some have tried GLP-1 medications elsewhere but stopped due to side effects or lack of support
- **Technology Comfort:** WhatsApp-native, comfortable with video calls, prefer mobile-first

**Specific Needs and Pain Points:**
1. **Medical Expertise:** Need endocrinologist who understands GLP-1 protocols, side effects, titration
2. **Continuity of Care:** Frustrated by "explain your problem again" with each new doctor
3. **Side Effect Support:** Nausea, constipation, fatigue‚Äîneed accessible guidance (WhatsApp, not appointments)
4. **Plateau Management:** Weight loss stalls‚Äîneed timely medical adjustments
5. **Lifestyle Integration:** Understand nutrition, exercise, supplements‚Äîbut need personalized guidance
6. **Community Support:** Feel isolated‚Äîwant to connect with others on similar journey
7. **Cost Transparency:** Frustrated by hidden costs‚Äîwant upfront pricing
8. **Trust Building:** Skeptical of "online doctors"‚Äîneed physical consultation first (especially Tier-2)

**Goals They're Trying to Achieve:**
- **Primary:** Lose 15-30kg and keep it off (sustainable weight loss)
- **Secondary:** Reverse pre-diabetes, manage PCOS symptoms, improve metabolic markers (HbA1c, cholesterol)
- **Tertiary:** Feel confident, energetic, in control of their health
- **Long-term:** Maintain metabolic health for life (prevent diabetes complications, cardiovascular disease)

**Acquisition Channels:**
- Doctor referrals (endocrinologists, bariatric specialists)
- Word-of-mouth (friend recommendations)
- Digital ads (Google, Meta targeting "GLP-1 India," "diabetes reversal," "PCOS treatment")
- Local events (health camps, corporate wellness)
- Content marketing (blogs, videos on metabolic health)

**Conversion Barriers:**
- "Is this a scam?" (trust deficit‚Äîsolved by physical consultations, credentials)
- "Too expensive" (‚Çπ3,500/month + medication)‚Äîmitigated by ROI messaging, free assessment
- "Not sure if I need this" (education gap)‚Äîaddressed by free metabolic health assessment

---

### Secondary User Segment: Corporate HR Managers (B2B Channel)

**Demographic Profile:**
- **Role:** HR Managers, Wellness Program Coordinators
- **Company Size:** IT companies, manufacturing (500-5,000 employees)
- **Location:** Vizag, Hyderabad, Bangalore (initial focus)
- **Budget:** ‚Çπ8,000-‚Çπ12,000/employee/year for wellness programs

**Current Behaviors and Workflows:**
- **Existing Wellness Programs:** Fitness challenges, mental health sessions, annual health checkups
- **Pain Points:** High health insurance claims (diabetes, obesity-related), low employee engagement in wellness
- **Decision Process:** ROI-focused‚Äîneed measurable outcomes (reduced claims, improved productivity)

**Specific Needs:**
- **ROI Demonstration:** Prove that metabolic health programs reduce long-term costs
- **Employee Engagement:** High participation rates (not just "wellness theater")
- **Measurable Outcomes:** Aggregate health metrics (anonymized) for leadership reporting
- **Convenience:** On-site health camps + digital platform access

**Goals:**
- Reduce health insurance claims by 20-30%
- Improve employee productivity (metabolic health impacts energy, focus)
- Demonstrate care for employee wellbeing (retention tool)
- Compliance with corporate wellness mandates

**Acquisition Channels:**
- Founder's Chamber of Commerce network
- Direct outreach to IT/manufacturing companies
- Corporate wellness partnerships (existing providers)

---

### Tertiary User Segment: Doctors (Endocrinologists) as Partners

**Demographic Profile:**
- **Specialty:** Endocrinologists, bariatric specialists
- **Experience:** 5-15 years, established practices
- **Location:** Vizag, Vijayawada, Hyderabad (Phase 1-2)
- **Frustrations:** Poor patient follow-up, administrative burden, limited telemedicine options

**Specific Needs:**
- **Patient Engagement:** Patients who actually follow treatment plans
- **Time Efficiency:** Reduce administrative work (scheduling, records, reminders)
- **Reputation Protection:** Quality platform that enhances, not damages, their brand
- **Fair Compensation:** ‚Çπ1,000-‚Çπ1,500 per consultation (metro), ‚Çπ500 (Tier-2)

**Goals:**
- Build telemedicine practice for future
- Better patient outcomes (higher compliance = better results)
- Additional income stream without operational overhead

---

## Goals & Success Metrics

### Business Objectives

1. **Acquire 1,000 users in Year 1** with blended CAC of ‚Çπ4,000 (targeting 200 in Phase 1 pilot, 800 in Phase 2 scale)
2. **Achieve ‚Çπ60L gross revenue in Year 1** (‚Çπ6,000 per user average, accounting for cohort ramping)
3. **Maintain 7.5x LTV:CAC ratio** (‚Çπ30,000 LTV √∑ ‚Çπ4,000 CAC) to demonstrate capital efficiency
4. **Achieve 71% gross margin** (platform leverage model with 70% subscription margin)
5. **Break even at 4,200 users** (between Year 2-3) with ‚Çπ1.5Cr seed funding
6. **Establish #1 metabolic health platform in Visakhapatnam** (50%+ brand awareness in target audience by Month 12)
7. **Raise Series A funding** (‚Çπ10-15Cr) by Month 18-24 after proving regional model

### User Success Metrics

1. **Clinical Outcomes:**
   - 70%+ of patients lose 10%+ body weight within 6 months
   - 60%+ of diabetic patients reduce HbA1c by 1.5+ points within 6 months
   - 50%+ of PCOS patients report improved symptoms (irregular periods, hirsutism)

2. **Engagement Metrics:**
   - 80%+ onboarding completion rate (frictionless signup critical)
   - 60%+ monthly active users (MAU) vs. total signups
   - 4+ app sessions per week (tracking, logging, community)
   - 2+ hours per month in video consultations

3. **Retention Metrics:**
   - 50%+ repeat consultation rate (vs. Nua's 50% benchmark)
   - <12% monthly churn rate (vs. industry 15-20%)
   - 8+ months average subscription duration
   - 60%+ of patients stay >6 months (switching cost validation)

4. **Satisfaction Metrics:**
   - NPS (Net Promoter Score) >50 (vs. general telemedicine 30-40)
   - 4.5+ star app rating (Google Play, App Store)
   - 90%+ patient satisfaction with doctor continuity
   - 85%+ patient satisfaction with WhatsApp support responsiveness

### Key Performance Indicators (KPIs)

**Acquisition KPIs:**
- **CAC by Channel:** Digital ads (‚Çπ3,750), Doctor referrals (‚Çπ2,667), Content/SEO (‚Çπ4,000), Events (‚Çπ5,000)
- **Conversion Funnel:** Website visit ‚Üí Signup (10%), Signup ‚Üí First consult (40%), First consult ‚Üí Paid subscription (60%)
- **Tier-1 vs Tier-2 Performance:** Track CAC, conversion, retention by geography

**Engagement KPIs:**
- **DAU/MAU Ratio:** Target 40%+ (daily active users √∑ monthly active users)
- **Content Consumption:** 5+ educational videos/articles watched per user per month
- **Community Participation:** 30%+ of users active in WhatsApp peer groups
- **WhatsApp Support Volume:** <2 hour average response time, 95%+ satisfaction

**Retention KPIs:**
- **Monthly Churn Rate:** <12% (vs. industry 15-20%)
- **LTV by Segment:** Standard (‚Çπ24,400), GLP-1 (‚Çπ58,570), PCOS (‚Çπ30,250)
- **Cohort Retention:** Month 3 (81%), Month 6 (66%), Month 12 (35%)
- **Program Completion Rate:** 50%+ complete 6-month programs

**Financial KPIs:**
- **MRR (Monthly Recurring Revenue):** ‚Çπ5L Month 6, ‚Çπ20L Month 12, ‚Çπ50L Month 18
- **Gross Margin:** 68-71% (subscription model leverage)
- **Contribution Margin:** Gross margin minus CAC (target 50%+)
- **Payback Period:** 1.8 months (CAC recovered in <2 months)

**Clinical KPIs:**
- **Average Weight Loss:** 10-15% body weight in 6 months
- **HbA1c Reduction:** 1.5+ points for diabetic patients
- **Medication Adherence:** 80%+ patients take medications as prescribed
- **Side Effect Resolution:** 90%+ side effects managed within 48 hours

---

## MVP Scope

### Core Features (Must Have)

**1. Patient Onboarding Flow:**
- **Description:** Frictionless, conversational signup (not form-heavy)
- **Rationale:** Every extra field = drop-off. Progressive data collection (start minimal, collect details as they engage)
- **Implementation:** Conversational UI, WhatsApp-style questions, get to value in 5 minutes or less

**2. Doctor Marketplace (Initial Launch):**
- **Description:** Browse and select from 5 endocrinologists (profiles, credentials, availability)
- **Rationale:** Trust building‚Äîpatients see doctor faces, credentials, experience. Not anonymous platform.
- **Implementation:** Doctor profile cards with photos, RMP certification, specializations, patient reviews (after launch)

**3. Physical Consultation Booking (Vizag Clinic):**
- **Description:** Book in-person consultations at Vizag clinic (initial visit builds trust)
- **Rationale:** Hybrid model differentiator‚Äîphysical first, digital follow-up. Critical for Tier-2 trust.
- **Implementation:** Calendar integration, SMS/WhatsApp reminders, clinic address/directions

**4. Video Consultation Platform:**
- **Description:** Secure video calls for follow-up consultations (after initial physical visit)
- **Rationale:** Convenience after trust established. Enables India-wide scalability.
- **Implementation:** Twilio or Jitsi integration, recording (with consent), screen sharing for lab results

**5. Basic EHR (Electronic Health Records):**
- **Description:** Patient medical history, weight tracking, medication dosage, side effects, lab results
- **Rationale:** Continuity of care‚Äîall providers (doctors, dieticians) access unified record. Eliminates "explain again" friction.
- **Implementation:** Database schema, role-based access, audit logs (DISHA compliance)

**6. Patient Tracking Dashboard:**
- **Description:** Weight, blood sugar, blood pressure, medication adherence, symptoms logged by patient
- **Rationale:** Data-driven care‚Äîdoctors see patterns, make informed decisions. Patient engagement tool.
- **Implementation:** Simple input forms, charts/graphs showing progress over time

**7. Doctor Voice-to-Text Notes:**
- **Description:** Doctors dictate clinical observations, auto-transcribed and filed in patient record
- **Rationale:** Time saver (10-15 min per patient)‚Äîmajor doctor adoption driver. More time for patient care.
- **Implementation:** Google Speech-to-Text API, medical terminology accuracy, review/edit before saving

**8. WhatsApp Support Integration:**
- **Description:** Patients can text doctor/nutritionist via WhatsApp (guaranteed <2 hour response)
- **Rationale:** Critical for first month when side effects emerge. Tier-2 users prefer WhatsApp over app.
- **Implementation:** WhatsApp Business API, routing to assigned providers, response time tracking

**9. Digital Prescription System:**
- **Description:** Doctors issue digital prescriptions (if regulations allow), or PDF prescriptions sent via WhatsApp
- **Rationale:** Convenience‚Äîpatients don't need to collect paper prescriptions. Regulatory dependent.
- **Implementation:** Prescription template, digital signature, secure delivery

**10. Subscription Management:**
- **Description:** Recurring billing (‚Çπ3,500/month standard, ‚Çπ6,000/month with GLP-1), payment gateway integration
- **Rationale:** Predictable revenue, reduces churn (subscription stickiness). Transparent pricing.
- **Implementation:** Razorpay/Stripe integration, automatic renewals, payment failure handling

**11. Transparent Pricing Page:**
- **Description:** Clear pricing tiers, what's included, no hidden costs
- **Rationale:** Competitive advantage vs. Elda/Adrita (no pricing). Builds trust.
- **Implementation:** Website page, comparison table (MetaboWell vs. competitors)

**12. Educational Content Library:**
- **Description:** Blog articles, videos on GLP-1 safety, obesity as disease, PCOS management, diabetes reversal
- **Rationale:** Education-first approach‚Äîbuilds trust, SEO value, reduces CAC (inbound leads).
- **Implementation:** CMS, SEO optimization, video hosting (YouTube/Vimeo)

**13. Visual Onboarding Experience:**
- **Description:** Relatable imagery (obese person walking), empowerment messaging ("Take control of your life"), "Science-led healthcare" positioning
- **Rationale:** First 30 seconds critical‚Äîovercome skepticism, shame barriers. Visual > text.
- **Implementation:** Landing page design, video testimonials (after launch), doctor credentials display

**14. Doctor Credentials Display:**
- **Description:** RMP certification, experience, specializations visible on profiles
- **Rationale:** Trust building‚Äîpatients see medical credibility. Not anonymous platform.
- **Implementation:** Doctor profile pages, credential verification, photo uploads

**15. Diagnostic Lab Partnership Integration:**
- **Description:** Partner with 1-2 labs (Thyrocare, Dr. Lal PathLabs) for home blood test visits, results integration into EHR
- **Rationale:** Patient convenience‚Äîno lab visits. Integrated care‚Äîlab results automatically in patient record.
- **Implementation:** Lab API integration, order placement, results delivery

**16. Free Metabolic Health Assessment (Lead Generation):**
- **Description:** 30-minute consultation (‚Çπ1,500 value) offered free as first touch
- **Rationale:** Lowers barrier to entry, educates market, generates qualified leads. Value-first positioning.
- **Implementation:** Landing page, booking system, doctor training on assessment protocol

**17. Compliance Infrastructure:**
- **Description:** DISHA (Digital Information Security in Healthcare Act) compliance, Digital Personal Data Protection Act preparation, consent frameworks
- **Rationale:** Legal requirement, trust building, competitive moat (compliance overhead for new entrants).
- **Implementation:** Data encryption, audit logs, consent management, legal review

**18. Payment Gateway Integration:**
- **Description:** Razorpay or Stripe India for payments
- **Rationale:** Secure, reliable payment processing. Reduces transaction friction.
- **Implementation:** Payment API, refund handling, invoice generation

### Out of Scope for MVP

**‚ùå Deliberately Excluded (Phase 2+):**

1. **Mobile App:** Web-first for MVP (mobile app in Phase 2)
2. **Peer Support Groups (In-Platform):** Start with WhatsApp groups manually, add to platform later
3. **Gamification:** Duolingo-style streaks, badges‚Äînice-to-have, add post-launch
4. **AI Pattern Recognition:** Need data first‚Äîadd in Phase 3
5. **Daily Micro-Content Drip:** Start with core library, add content pipeline later
6. **Smart Scale Integration/Wearables:** Manual weight entry fine for MVP
7. **Multi-Language Support:** English + Hindi only for V1, expand to regional languages (Telugu) in Phase 2
8. **Mood/Emotional Tracking:** "How We Feel" adaptation‚Äîadd post-launch based on demand
9. **Netflix-Style Content Recommendations:** V1 has static content library
10. **Swiggy-Style Delivery Tracking:** Simple notifications adequate for MVP
11. **Fitness Tracking Integration:** Nice-to-have but not core value proposition
12. **Recipe Database:** Dieticians provide personalized meal plans instead (higher value)
13. **Advanced Social Features:** No public profiles, likes, social feed (keep simple peer groups only)
14. **Pharmacy Fulfillment:** Partner referrals only (not direct fulfillment in MVP)
15. **Corporate Wellness Dashboard:** B2B features in Phase 3

### MVP Success Criteria

**Launch Readiness (Month 6):**
- ‚úÖ 5 endocrinologists onboarded and trained
- ‚úÖ 3 dieticians onboarded and trained
- ‚úÖ Physical clinic operational in Vizag (1,000-1,500 sq ft)
- ‚úÖ Video consultation platform tested and reliable (<5% technical failures)
- ‚úÖ EHR system functional (all providers can access patient records)
- ‚úÖ WhatsApp Business API operational (<2 hour response time)
- ‚úÖ Payment gateway tested (100% transaction success rate)
- ‚úÖ Compliance infrastructure validated (legal review complete)
- ‚úÖ Educational content library live (20+ articles, 10+ videos)
- ‚úÖ Free assessment landing page live (lead generation funnel)

**Beta Testing Success (Month 6):**
- ‚úÖ 20-50 beta patients recruited (mix of Tier-1 and Tier-2)
- ‚úÖ 70%+ onboarding completion rate
- ‚úÖ <5% technical issues causing failed consultations
- ‚úÖ 4+ star average satisfaction rating
- ‚úÖ 60%+ of patients complete second consultation (retention signal)
- ‚úÖ Doctor satisfaction scores >4/5 (platform usability, time savings)

**Public Launch Success (Month 8):**
- ‚úÖ 100 paying patients acquired (free assessment ‚Üí paid conversion >30%)
- ‚úÖ ‚Çπ3.5L+ MRR (100 users √ó ‚Çπ3,500/month)
- ‚úÖ 50%+ NPS (Net Promoter Score)
- ‚úÖ 80%+ onboarding completion rate (frictionless signup validated)
- ‚úÖ <12% monthly churn rate (retention validated)
- ‚úÖ 5+ success stories captured (before/after transformations, testimonials)

---

## Post-MVP Vision

### Phase 2 Features (Months 7-18)

**Enhanced Platform:**
1. **Mobile App Launch:** Flutter (Android first, iOS later) for on-the-go access
2. **Advanced Symptom Tracking:** Food diary, exercise logging, sleep tracking, mood logging
3. **WhatsApp Community Groups:** In-platform peer support (moderated by nutritionists, 10-15 patients per group)
4. **Nutrition Coaching Module:** Meal plans, recipes, grocery lists, dietician video consultations
5. **Mental Health Integration:** Partner psychologists for stress/depression management (holistic care)
6. **Regional Language Support:** Telugu, Hindi (Tier-2 penetration)
7. **Diagnostic Partnerships Expansion:** Multiple labs per city (choice and redundancy)
8. **Pharmacy Partnerships:** Medication delivery coordination (not just referrals)
9. **Doctor Q&A Sessions:** Monthly community sessions with experts
10. **Cohort-Based Programs:** Groups starting GLP-1 together (shared journey, built-in peer support)

**Geographic Expansion:**
- **Vijayawada:** Physical consultations 1-2x/month (partner clinic)
- **Hyderabad:** Partner clinic for consultations (hybrid model replication)

**Target:** 1,000 users by Month 18

---

### Phase 3 Features (Months 19-36)

**GLP-1 Program Launch:**
1. **Full GLP-1 Therapy Program:** Protocols, medication management, side effect monitoring, titration schedules
2. **CGM Integration:** Continuous glucose monitoring for diabetes/pre-diabetes patients (Freestyle Libre, Dexcom)
3. **AI-Powered Adherence Nudges:** Automated check-ins based on symptom patterns (missed medications, weight plateau)
4. **Corporate Wellness Dashboard:** Employer portals, aggregate health metrics (anonymized), ROI reporting
5. **Insurance Integration:** Claim processing, cashless consultations (first-mover for metabolic health coverage)
6. **Partner Education Modules:** Spouse/family education on supporting patient journey
7. **Metabolic Health Score:** Proprietary metric (0-100) combining HbA1c, weight, BMI, hormone levels
8. **Family Metabolic Health Plans:** Husband + wife + parents together (shared lifestyle, family discount)

**Geographic Expansion:**
- 10+ Tier-2 cities (Vizag, Vijayawada, Hyderabad, Guntur, Kakinada, etc.)
- Regional language content (Telugu, Hindi, Marathi, Tamil)

**Target:** 5,000 users by Month 36

---

### Long-Term Vision (3-5 Years)

**Platform Evolution:**
- **Metabolic Health Lifestyle Community:** Beyond weight loss to lifelong wellness identity
- **Multi-Condition Expansion:** Diabetes, PCOS, hypertension, menopause on same platform infrastructure
- **Research Data Platform:** Anonymized Indian GLP-1 real-world evidence for pharma partnerships (Eli Lilly, Novo Nordisk)
- **Medical Education Tool:** Training platform for doctors learning GLP-1 protocols
- **White-Label SaaS:** License platform infrastructure to hospitals/clinics

**Scale Metrics:**
- **Pan-India Reach:** Tier-1, Tier-2, Tier-3 cities at scale
- **50,000+ Patients:** Largest GLP-1 community in India (network effects)
- **‚Çπ100Cr+ Revenue:** Category-defining brand ("MetaboWell = metabolic health")
- **International Expansion:** Adapt model for other emerging markets (Southeast Asia, Middle East)

**Technology Innovation:**
- **Advanced AI Health Coach:** Sophisticated personalization and prediction
- **Wearable Ecosystem Integration:** Fitness trackers, continuous glucose monitors, smart scales
- **Voice/Conversational AI:** Natural language interaction, accessibility for all literacy levels
- **Blockchain Health Records:** Patient-controlled, secure, portable medical records

---

## Technical Considerations

### Platform Requirements

- **Target Platforms:** Web-first (desktop + mobile responsive), Android app (Phase 2), iOS app (Phase 3)
- **Browser/OS Support:** Chrome, Safari, Firefox (latest 2 versions), Android 8+, iOS 12+
- **Performance Requirements:** Page load <3 seconds, video consultation latency <200ms, 99.5% uptime

### Technology Preferences

- **Frontend:** React (web), React Native or Flutter (mobile app‚ÄîFlutter preferred for cross-platform)
- **Backend:** Node.js (Express) or Python (Django/FastAPI) for API, microservices architecture
- **Database:** PostgreSQL (primary), Redis (caching, sessions), MongoDB (optional for unstructured data)
- **Hosting/Infrastructure:** AWS or GCP with healthcare compliance (HIPAA/DISHA equivalent), auto-scaling, CDN (CloudFront/Cloudflare)

### Architecture Considerations

- **Repository Structure:** Monorepo or multi-repo (preference TBD‚Äîdepends on team size)
- **Service Architecture:** Microservices (user service, consultation service, EHR service, payment service) vs. modular monolith (start monolithic, split later)
- **Integration Requirements:**
  - Video consultation: Twilio Video or Jitsi Meet
  - WhatsApp: WhatsApp Business API
  - Payment: Razorpay or Stripe India
  - Voice-to-text: Google Speech-to-Text API
  - Email/SMS: SendGrid, Twilio SMS
  - Lab integration: Lab API (Thyrocare, Dr. Lal PathLabs)
- **Security/Compliance:**
  - DISHA compliance (Digital Information Security in Healthcare Act)
  - Digital Personal Data Protection Act (DPDP Act) preparation
  - ISO 27001 certification (Phase 2)
  - End-to-end encryption for patient data
  - Role-based access control (RBAC) for providers
  - Audit logs for all data access
  - Consent management frameworks

---

## Constraints & Assumptions

### Constraints

**Budget:**
- **Seed Funding:** ‚Çπ1.5Cr (‚Çπ15M) for 12-18 months runway
- **Allocation:** Technology (35% = ‚Çπ52.5L), Marketing (27% = ‚Çπ40L), Operations (27% = ‚Çπ40L), Compliance (13% = ‚Çπ20L), Contingency (7% = ‚Çπ10L)
- **Monthly Burn Rate:** ‚Çπ12.5L average (Year 1)

**Timeline:**
- **MVP Development:** 6 months (Months 1-6)
- **Beta Testing:** 2 months (Months 6-8)
- **Public Launch:** Month 8
- **Phase 2 Start:** Month 7 (parallel with MVP completion)
- **Break-even Target:** Month 18-24 (4,200+ users)

**Resources:**
- **Team:** Founding team (business, operations), outsourced development (MVP), UI/UX designer (consultant), content creator/medical writer (consultant), healthcare regulatory lawyer (consultant)
- **Physical Infrastructure:** Clinic space in Vizag (1,000-1,500 sq ft, ‚Çπ30-50K/month rent)
- **Doctor Network:** 5 endocrinologists (Phase 1), 3 dieticians (Phase 1)

**Technical:**
- **MVP Complexity:** Web-first (no mobile app), outsourced development (faster to market)
- **Regulatory Dependency:** Telemedicine prescription regulations may require hybrid model (physical first visit mandatory)
- **Integration Constraints:** Lab/pharmacy partnerships require API availability (may need manual workflows initially)

### Key Assumptions

**Market Assumptions:**
1. **Willingness to Pay:** ‚Çπ3,500/month subscription acceptable to target market (validated through pricing survey)
2. **GLP-1 Adoption:** 25% of patients will opt for GLP-1 therapy (‚Çπ6,000/month + medication)
3. **Retention:** Average subscription duration 8 months (12% monthly churn)
4. **CAC Reduction:** Blended CAC drops from ‚Çπ4,000 (Year 1) to ‚Çπ1,400 (Year 3) through brand building, referrals, marketing efficiency

**Operational Assumptions:**
1. **Doctor Commission:** 30% commission on consultations (‚Çπ1,500 consultation ‚Üí ‚Çπ450 platform revenue)
2. **Subscription Margin:** 70% margin on subscriptions (‚Çπ3,500 subscription ‚Üí ‚Çπ2,450 platform revenue)
3. **Free Assessment Conversion:** 30-40% of free assessments convert to paid subscriptions
4. **Physical ‚Üí Digital Conversion:** 80% of physical consultation patients book video follow-ups

**Competitive Assumptions:**
1. **Competitive Window:** 24-36 months before HealthifyRx/Mosaic enter Tier-2 markets aggressively
2. **Price Pressure:** Generic semaglutide (2026) will reduce GLP-1 costs 85-90%, expanding market
3. **Regional Advantage:** Hybrid model defensible moat (digital-only players can't easily replicate)

**Regulatory Assumptions:**
1. **Telemedicine Prescriptions:** GLP-1 medications can be prescribed via telemedicine after initial in-person visit (to be validated with healthcare lawyer)
2. **DISHA Compliance:** Current platform architecture can achieve compliance (data encryption, audit logs, consent frameworks)
3. **DPDP Act:** Platform can adapt to upcoming privacy regulations (flexible consent management)

**Technology Assumptions:**
1. **Video Platform Reliability:** Twilio/Jitsi can achieve <5% technical failure rate
2. **WhatsApp API:** WhatsApp Business API can handle <2 hour response time for support queries
3. **Voice-to-Text Accuracy:** Google Speech-to-Text achieves 90%+ accuracy for medical terminology

---

## Risks & Open Questions

### Key Risks

**1. Regulatory Compliance Risk (CRITICAL - Existential):**
- **Description:** Indian Telemedicine Practice Guidelines may require in-person first consultation for GLP-1 medications (Schedule H/H1/X drugs). Could force hybrid model from day 1 or block telemedicine prescriptions entirely.
- **Impact:** Could fundamentally change MVP scope (need clinic partnerships before launch, adds 2-3 months), or require pivot to post-prescription support only model.
- **Mitigation:** Engage healthcare regulatory lawyer immediately (Week 1-4), understand GLP-1 Schedule classification, determine first consultation requirements, finalize business model based on findings.

**2. Trust Deficit Risk (HIGH - Acquisition Barrier):**
- **Description:** "Is this a scam?" perception in first 30 seconds. Zero social proof at launch (no testimonials, reviews, track record). Chicken-and-egg: need patients to build proof, need proof to get patients.
- **Impact:** Low conversion rates, high CAC, slow growth.
- **Mitigation:** "Do things that don't scale" (personal outreach, doctor referrals, local events), university/research partnership for credibility, transparent credentials display, free assessment to build trust before commitment.

**3. Doctor Recruitment Risk (HIGH - Operational Dependency):**
- **Description:** Need credible endocrinologists willing to experiment with telemedicine model. Reputation protection concerns (bad reviews, social media attacks). May demand higher commissions or leave for competitors.
- **Impact:** Delayed launch, limited capacity, quality issues.
- **Mitigation:** Reputation protection protocols (internal dispute resolution, verified reviews only), competitive compensation (‚Çπ1,000-‚Çπ1,500 per consultation), pilot proof before committing (show evidence model works), voice-to-text notes as adoption driver (time savings).

**4. Competitive Response Risk (MEDIUM - Market Timing):**
- **Description:** HealthifyRx, Mosaic Wellness, Apollo could launch metabolic health verticals or enter Tier-2 markets aggressively. Well-funded competitors (‚Çπ100Cr+ funding) could outspend on marketing, undercut pricing.
- **Impact:** Market share erosion, CAC inflation, pricing pressure.
- **Mitigation:** Move fast (launch in 6 months), build regional dominance (Vizag first), emphasize personal touch moat (hard to copy at scale), establish category leadership (thought leadership, content marketing).

**5. Patient Retention Risk (MEDIUM - Churn Sensitivity):**
- **Description:** Patients may leave after losing weight (6-12 months), feel they can manage maintenance alone, or doctors may poach patients off-platform.
- **Impact:** Lower LTV than projected (‚Çπ30K), unsustainable unit economics.
- **Mitigation:** Shift from transactional to relational ("metabolic health lifestyle community"), community building (peer groups, WhatsApp), long-term maintenance programs (post-GLP-1 off-ramp), medical reality helps (weight rebound = retention).

**6. Pricing Sensitivity Risk (MEDIUM - Market Acceptance):**
- **Description:** ‚Çπ3,500/month + medication (‚Çπ6,000-‚Çπ20,000/month total) may be too expensive for Tier-2 market. Competitors could launch free telemedicine or lower pricing.
- **Impact:** Low conversion rates, need to reduce pricing (hurts margins).
- **Mitigation:** Results justify premium (testimonials, before/after transformations), demonstrate ROI (platform fee tiny vs. diabetes complications), pricing flexibility (tiered plans, corporate subsidies), free assessment lowers barrier.

**7. Technology MVP Risk (MEDIUM - Quality Concerns):**
- **Description:** Outsourced development may result in buggy platform, poor UX, unreliable video consultations. Could damage brand, reduce retention.
- **Impact:** Low satisfaction, high churn, reputation damage.
- **Mitigation:** Rigorous QA, beta testing (20-50 users), reliable vendor selection (SLA agreements), plan in-house CTO hire (Phase 2 after seed).

**8. Pharmacy Partnership Risk (LOW-MEDIUM - Fulfillment Dependency):**
- **Description:** Pharmacy partnerships (or direct manufacturer partnerships) may be slow to establish, unreliable fulfillment, or demand unfavorable terms.
- **Impact:** Medication access delays, patient frustration, revenue loss.
- **Mitigation:** Multiple pharmacy partners (redundancy), direct manufacturer outreach (Eli Lilly, Novo Nordisk) in parallel, manual workflows initially if needed.

### Open Questions

**Critical Path Questions (MUST ANSWER BEFORE BUILDING):**

1. **What are the legal requirements for prescribing GLP-1 medications via telemedicine in India?** (Schedule classification, first consultation requirements, state-by-state variations)
2. **Is first consultation required to be in-person, or can it be done remotely?** (Determines if hybrid model needed from day 1)
3. **What consent and documentation is required for telemedicine GLP-1 prescriptions?** (Regulatory compliance requirements)
4. **What's the optimal pricing model: Per-consultation, subscription, or hybrid?** (Pricing survey needed)
5. **What patient lifetime value can we expect with 3-5 year retention?** (Current assumption: ‚Çπ30K conservative, may be higher)

**Business Model Questions:**

6. **Should we pursue direct Eli Lilly partnership or start with pharmacy network?** (Speed vs. strategic value trade-off)
7. **What do pharma companies typically offer/want in patient education partnerships?** (Partnership terms, value exchange)
8. **What lab partnership terms are standard?** (Pricing, integration, exclusivity)
9. **How many paying patients needed to break even?** (Current estimate: 4,200 users‚Äîvalidate with actual costs)

**Product Questions:**

10. **Should we build from scratch or use white-label telemedicine platform?** (Speed vs. customization trade-off)
11. **What's minimum viable community feature?** (WhatsApp groups vs. in-app features)
12. **How critical is mood/emotional tracking really?** (Validate with user research‚Äîmay be Phase 2)
13. **Should daily micro-content be in MVP or post-launch?** (Content creation resource constraint)

**Market Questions:**

14. **What's the real size of addressable market for GLP-1 in India?** (Current and projected‚Äîvalidate market sizing)
15. **How will generic semaglutide arrival next year change market dynamics?** (Pricing, adoption, competition)
16. **What are cultural nuances in Tier-2 cities that affect messaging and features?** (User research needed)
17. **How do patients currently handle obesity treatment?** (Alternatives assessment‚Äîgym, diets, other platforms)

**Competitive Questions:**

18. **What is Tata 1mg/Practo/PharmEasy doing in weight loss/diabetes management space?** (Monitor for competitive moves)
19. **Are hospital chains (Apollo, Fortis) launching telemedicine weight loss programs?** (Competitive intelligence)
20. **What's the competitive moat if well-funded players enter aggressively?** (Personal touch defensibility validation)

### Areas Needing Further Research

**Regulatory Deep Dive (URGENT - Week 1-4):**
- Indian Telemedicine Practice Guidelines for GLP-1 prescriptions
- Schedule H/H1/X drug classification and implications
- First consultation requirements (in-person vs. remote)
- Prescription validity and renewal protocols
- Interstate telemedicine practice rules
- Liability frameworks for teleconsultations
- **Action:** Engage healthcare regulatory lawyer, comprehensive legal opinion

**Market Research (Month 1-3):**
- User research in Tier-2 cities (willingness to pay, trust factors, UX testing)
- Competitive analysis update (what are 1mg, Practo, hospital chains doing?)
- Doctor compensation benchmarking (what do telemedicine doctors typically earn?)
- Pharmacy economics (margins, delivery costs, patient preferences)
- Pricing sensitivity survey (100 target customers on ‚Çπ3,500/month)

**Partnership Strategy (Month 1-6):**
- Eli Lilly partnership value exchange (what do they want, what can we offer?)
- Lab partnership terms (pricing, integration requirements, exclusivity)
- Pharmacy decision (direct pharma vs. network‚Äîneeds strategic clarity)
- Clinic partnerships (if hybrid model needed, which clinics, what terms?)

**Technology Decisions (Month 1-2):**
- Platform selection (build from scratch vs. white-label telemedicine platform)
- EHR standards (India Stack, ABDM integration for interoperability)
- Video consultation infrastructure (Twilio vs. Agora vs. others‚Äîcost, reliability)
- WhatsApp Business API (requirements, costs, limitations)
- Voice-to-text (accuracy for medical terminology, cost)

**Go-to-Market Strategy (Month 2-4):**
- Channel-specific acquisition plans (personal outreach, doctor referrals, digital ads)
- Budget allocation across channels (‚Çπ40L Year 1 marketing)
- Tier-1 vs. Tier-2 messaging differences
- Content marketing strategy (SEO, blog, videos)
- Community building tactics (WhatsApp groups, workshops)

---

## Appendices

### A. Research Summary

**Market Research Findings:**

1. **Market Size:**
   - Weight management market: $3.7B (2024), 9.5% CAGR
   - Telemedicine market: $10.6B (2024) ‚Üí $25B (2030), 20.7% CAGR
   - 135M+ Indians with obesity and metabolic disorders
   - GLP-1 market nascent (Ozempic approved Oct 2024, Mounjaro launched)

2. **Competitive Landscape:**
   - **Direct Competitors:** HealthifyRx (GLP-1 leader), Mohak Bariatrics
   - **Indirect Competitors:** Veera Health (PCOS), Mosaic Wellness (scale), Practo, Apollo, Tata 1mg
   - **Key Gap:** No platform integrates endocrinology + GLP-1 + nutrition + digital follow-up comprehensively
   - **Pricing Range:** ‚Çπ299-‚Çπ1,500 (consultations), ‚Çπ2,000-‚Çπ5,000/month (programs), ‚Çπ48,000-‚Çπ80,000 (GLP-1 therapy)

3. **User Research (From Brainstorming):**
   - Education journey required: GLP-1 safety ‚Üí Obesity as disease ‚Üí Treatment works ‚Üí Results
   - Trust barriers: "Is this a scam?" (first 30 seconds critical)
   - Preferred channels: Doctor referrals, word-of-mouth, eventually digital ads
   - Price sensitivity: ‚Çπ6,000-‚Çπ20,000/month total (medication + platform) acceptable with ROI justification

**Competitive Analysis Summary:**

- **HealthifyRx:** Digital-only, coach-led, metro-centric, premium pricing (‚Çπ48K-‚Çπ80K)
- **Veera Health:** PCOS-only, no GLP-1, no diabetes, no physical consultations
- **Mosaic Wellness:** Generalist, product-focused, no endocrinologist specialists, no GLP-1 programs
- **Apollo 24/7:** Transactional consultations, no structured programs, expensive (‚Çπ300-‚Çπ1,500)
- **Practo:** Marketplace model, no continuity, no specialization, no programs

**Strategic Positioning:**

- **MetaboWell Differentiation:** Hybrid model, endocrinologist-led, integrated care, Tier-2 focus, transparent pricing
- **Moat:** Switching costs (doctor relationships), regional dominance (physical presence), personal touch (hard to copy at scale)

---

### B. Stakeholder Input

**Founder Vision (From Initial Thoughts):**
- Platform to connect patients with doctors, labs, pharmacies, dieticians for GLP-1 journey
- Critical support mechanisms: WhatsApp facility, plateau management, peer support, medication reminders
- Integration as value: All providers access unified EHR, eliminating friction
- Long-term relationships: Not weight loss program but metabolic health companion (3-5 years)

**Brainstorming Session Insights:**
- Continuous care vs. prescribe & abandon (massive gap in Indian healthcare)
- Personal touch as moat (high-touch service big platforms can't replicate)
- Community creates retention (sense of belonging keeps patients engaged)
- Education-first approach (convince patients GLP-1 is safe, obesity is disease)
- Regulatory research critical (telemedicine prescription regulations existential risk)

**Differentiation Brainstorming Insights:**
- "Doctor as Hero, Not App" (human connection in digital age)
- "Regional Roots, National Wings" (Tier-2 first strategy)
- "Metabolic Health Partner, Not Weight Loss App" (holistic positioning)
- "Earn Trust, Then Scale" (relationship-first business model)

**Unit Economics Validation:**
- LTV:CAC ratio 7.5x (excellent capital efficiency)
- Payback period 1.8 months (fast return on marketing spend)
- Gross margin 68-71% (high-margin digital model)
- Break-even at 4,200 users (achievable by Year 2-3)

---

### C. References

**Market Research:**
- Grand View Research: Weight Management Market Report (2024)
- IMARC: Telemedicine Market in India (2024)
- Practo: Tier-2 Telemedicine Growth Data (2024)

**Competitive Intelligence:**
- HealthifyRx website, pricing pages, app store reviews
- Veera Health, Mosaic Wellness, Apollo 24/7 competitive analysis
- Existing competitive analysis documents (Femwell, women's hormonal health)

**Regulatory:**
- Indian Telemedicine Practice Guidelines (2020)
- Digital Information Security in Healthcare Act (DISHA)
- Digital Personal Data Protection Act (DPDP Act) - upcoming

**Internal Documents:**
- `docs/brainstorming-session-results.md` - Comprehensive strategic planning session
- `docs/metabowell-competitive-analysis.md` - Detailed competitive landscape analysis
- `docs/metabowell-differentiation-brainstorming.md` - Positioning and differentiation strategy
- `docs/unit-economics-model.md` - Financial framework and unit economics validation
- `docs/initial-thoughts.md` - Founder's original vision and problem statement

**External Resources:**
- Eli Lilly India: Mounjaro launch, $1B plant investment announcement
- Novo Nordisk: Ozempic/Wegovy patent expiration timeline (2026)
- Tata 1mg: Partnership with HealthifyRx for GLP-1 programs

---

## Next Steps

### Immediate Actions (Week 1-4)

1. **üö® REGULATORY RESEARCH (BLOCKING - Week 1-4):**
   - Engage healthcare regulatory lawyer
   - Research Indian Telemedicine Practice Guidelines for GLP-1 prescriptions
   - Understand GLP-1 Schedule classification and prescription requirements
   - Determine if in-person first visit mandatory
   - Finalize business model based on findings (pure digital vs. hybrid)

2. **Pricing Strategy Finalization (Week 1-2):**
   - Conduct pricing survey (100 target customers on ‚Çπ3,500/month willingness-to-pay)
   - Benchmark against competitors (HealthifyRx ‚Çπ48K-‚Çπ80K, Veera ‚Çπ2,100/month)
   - Finalize pricing tiers (Standard ‚Çπ3,500, GLP-1 ‚Çπ6,000 + meds)

3. **Doctor Recruitment Preparation (Week 2-4):**
   - List 20-30 potential doctor targets (endocrinologists, bariatric specialists in Vizag)
   - Draft doctor pitch deck (value proposition, compensation, reputation protection)
   - Prepare compensation proposal (‚Çπ1,000-‚Çπ1,500 per consult, performance-based model)
   - Identify early adopter doctors (already prescribing GLP-1, interested in telemedicine)

4. **Competitive Intelligence Setup (Week 1-2):**
   - Set up competitive monitoring dashboard (weekly pricing checks, feature updates)
   - Mystery shop HealthifyRx, Veera, Mosaic (understand user experience)
   - Document competitor weaknesses (positioning opportunities)

5. **Financial Modeling Refinement (Week 2-3):**
   - Validate unit economics assumptions (CAC, LTV, margins)
   - Update investor deck with validated metrics (LTV:CAC 7.5x, payback 1.8 months)
   - Calculate break-even point (4,200 users)

### Pre-Launch Actions (Month 2-6)

6. **Partnership Development (Month 2-3):**
   - Lab partnerships (Thyrocare, Dr. Lal PathLabs) - home blood test visits, API integration
   - Pharmacy strategy decision (direct manufacturer vs. pharmacy network)
   - University/research partnership (for credibility - academic affiliation)

7. **Technology Development (Month 3-5):**
   - Select development partner (outsourced MVP) or white-label platform
   - Architecture design (microservices vs. monolithic - start monolithic, split later)
   - Development priorities (onboarding ‚Üí doctor marketplace ‚Üí video consultations ‚Üí EHR ‚Üí tracking ‚Üí WhatsApp ‚Üí payment)

8. **Content Development (Month 3-5):**
   - Educational video scripts (GLP-1 safety, obesity as disease, what to expect)
   - Blog articles (SEO-focused: "diabetes reversal," "PCOS + weight loss," "GLP-1 therapy India")
   - Visual onboarding experience (landing page design, doctor profiles)

9. **Beta Testing Preparation (Month 6):**
   - Recruit 20-50 beta patients (personal networks, doctor referrals)
   - Test all user flows (onboarding, consultation booking, video calls, WhatsApp support)
   - Gather feedback systematically (weekly surveys, one-on-one interviews)

10. **Public Launch Preparation (Month 7-8):**
    - Marketing campaign launch ("Doctor-led metabolic health partner")
    - "Do things that don't scale" acquisition (personal outreach, local events, doctor referrals)
    - Capture success stories (video testimonials, before/after transformations)

### PM Handoff

This Project Brief provides the full context for **MetaboWell**. The document synthesizes insights from comprehensive brainstorming sessions, competitive analysis, differentiation strategy, and unit economics validation.

**Key Highlights for PRD Generation:**
- **MVP Scope:** 18 core features (must-haves) clearly defined, with 15 features explicitly out-of-scope
- **User Segments:** Primary (obese/metabolic patients), Secondary (corporate HR), Tertiary (doctors as partners)
- **Success Metrics:** Business objectives, user success metrics, and KPIs quantified
- **Risks:** Critical regulatory risk (existential), trust deficit, doctor recruitment, competitive response
- **Constraints:** ‚Çπ1.5Cr seed funding, 6-month MVP timeline, outsourced development

**Critical Dependencies:**
- **Regulatory research MUST be completed before building** (determines hybrid model requirements)
- **Pricing survey validation needed** (‚Çπ3,500/month acceptance)
- **Doctor recruitment critical path** (need 5 endocrinologists for launch)

**Next Document:** Please start in 'PRD Generation Mode', review this brief thoroughly, and work with the user to create the PRD section by section as the template indicates, asking for any necessary clarification or suggesting improvements.

---

**Document Status:** Ready for PRD Generation  
**Owner:** Mary, Business Analyst  
**Next Review:** After regulatory research completion (Week 4)

